首页> 外文期刊>Journal of Hainan Medical University >Covered by CAS, CSA, IC, CAB Abstract, Global Health, Chinese Scientific Core Journal, Chinese Scientific Journal Effect of paecilomyces hepiall chen on serum inflammatory factors, oxidative stress and renal function in patients with diabetic nephropathy
【24h】

Covered by CAS, CSA, IC, CAB Abstract, Global Health, Chinese Scientific Core Journal, Chinese Scientific Journal Effect of paecilomyces hepiall chen on serum inflammatory factors, oxidative stress and renal function in patients with diabetic nephropathy

机译:收录于CAS,CSA,IC,CAB摘要,《全球卫生》,《中国科学核心杂志》,《中国科学杂志》。拟青霉菌陈对糖尿病肾病患者血清炎性因子,氧化应激和肾功能的影响

获取原文
       

摘要

Objective: To investigate the effect of paecilomyces hepiall chen on serum inflammatoryfactors, oxidative stress and renal function in patients with diabetic nephropathy. Methods: Atotal of 124 cases of diabetic nephropathy patients were selected as the research object, basedon the random data table they were divided into the control group and the observation group,62 cases in each group, two groups of patients were given conventional treatment, on thisbasis, the patients in the control group were treated with valsartan capsules treatment, whilepatients in the observation group were given valsartan capsules combined with paecilomyceshepiall chen treatment. To compare the levels of blood pressure [systolic blood pressure (SBP),diastolic blood pressure (DBP)], inflammatory factor [tumor necrosis factor -α (TNF-α),high sensitive C reactive protein (hs-CRP)], oxidative stress [superoxide dismutase (SOD),malondialdehyde (MDA)] and renal function index [serum creatinine (Scr), urea nitrogen(BUN)] of the two groups before and after treatment. Results: Before treatment, there were nosignificantly different of the levels of SBP, DBP, TNF-α, hs-CRP, SOD, MDA, Scr and BUNbetween the two groups. After treatment, the observation group SBP, DBP, TNF-α, hs-CRP,MDA, Scr and BUN level were (135.71±15.64) mmHg, (84.96±13.97) mmHg, (46.37±5.92)ng/L, (5.99±0.94) mg/L, (20.91±2.38) μmol/L, (83.86±10.16) μmol/L and (6.53±1.37) mmol/L, were significantly lower than before treatment, and after treatment the TNF-α, hs-CRP,MDA, Scr and BUN in observation group were significantly lower than the control group;Compared with the levels in the same group before treatment, the two groups of SOD levelswere significantly increased, and the observation group [(93.21±7.06) U/mL] was significantlyhigher than the control group [(79.84±6.12) U/mL]. Conclusion: Paecilomyces hepiall chen ontreatment of diabetic nephropathy, can effectively relieve chronic inflammation and oxidativestress, improve renal function, has an important clinical value.
机译:目的:探讨青枯菌对糖尿病肾病患者血清炎性因子,氧化应激和肾功能的影响。方法:选择124例糖尿病肾病患者作为研究对象,根据随机数据表将其分为对照组和观察组,每组62例,两组患者进行常规治疗。在此基础上,对照组患者给予缬沙坦胶囊治疗,观察组患者给予缬沙坦胶囊联合青霉素治疗。比较血压[收缩压(SBP),舒张压(DBP)],炎性因子[肿瘤坏死因子-α(TNF-α),高敏C反应蛋白(hs-CRP)],氧化水平两组治疗前后的应激反应[超氧化物歧化酶(SOD),丙二醛(MDA)]和肾功能指数[血清肌酐(Scr),尿素氮(BUN)]。结果:治疗前两组之间的SBP,DBP,TNF-α,hs-CRP,SOD,MDA,Scr和BUN水平无显着差异。治疗后观察组的SBP,DBP,TNF-α,hs-CRP,MDA,Scr和BUN水平分别为(135.71±15.64)mmHg,(84.96±13.97)mmHg,(46.37±5.92)ng / L,(5.99) ±0.94 mg / L,(20.91±2.38)μmol/ L,(83.86±10.16)μmol/ L和(6.53±1.37)mmol / L显着低于治疗前,治疗后TNF-α,hs观察组的-CRP,MDA,Scr和BUN明显低于对照组;与治疗前同一组比较,两组SOD水平明显升高,观察组[(93.21±7.06)U / mL]显着高于对照组[(79.84±6.12)U / mL]。结论:拟青霉菌素治疗糖尿病肾病,能有效缓解慢性炎症和氧化应激,改善肾功能,具有重要的临床价值。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号